Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00646191 · COMPLETED
Trial details
- NCT number
- NCT00646191
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2004-06-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.